[go: up one dir, main page]

BRPI1010900A2 - compostos antivirais heterocíclicos - Google Patents

compostos antivirais heterocíclicos

Info

Publication number
BRPI1010900A2
BRPI1010900A2 BRPI1010900A BRPI1010900A BRPI1010900A2 BR PI1010900 A2 BRPI1010900 A2 BR PI1010900A2 BR PI1010900 A BRPI1010900 A BR PI1010900A BR PI1010900 A BRPI1010900 A BR PI1010900A BR PI1010900 A2 BRPI1010900 A2 BR PI1010900A2
Authority
BR
Brazil
Prior art keywords
antiviral compounds
heterocyclic antiviral
heterocyclic
compounds
antiviral
Prior art date
Application number
BRPI1010900A
Other languages
English (en)
Inventor
Alfred Sui-Ting Lui
Elbert Chin
Francisco Xavier Talamas
Jim Li
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI1010900A2 publication Critical patent/BRPI1010900A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI1010900A 2009-05-20 2010-05-17 compostos antivirais heterocíclicos BRPI1010900A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17985709P 2009-05-20 2009-05-20
PCT/EP2010/056686 WO2010133528A1 (en) 2009-05-20 2010-05-17 Heterocyclic antiviral compounds

Publications (1)

Publication Number Publication Date
BRPI1010900A2 true BRPI1010900A2 (pt) 2016-03-15

Family

ID=42488524

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1010900A BRPI1010900A2 (pt) 2009-05-20 2010-05-17 compostos antivirais heterocíclicos

Country Status (14)

Country Link
US (1) US20100297073A1 (pt)
EP (1) EP2432554A1 (pt)
JP (1) JP2012527420A (pt)
KR (1) KR20120024784A (pt)
CN (1) CN102448548A (pt)
AR (1) AR078412A1 (pt)
AU (1) AU2010251272A1 (pt)
BR (1) BRPI1010900A2 (pt)
CA (1) CA2761279A1 (pt)
IL (1) IL216026A0 (pt)
MX (1) MX2011012240A (pt)
SG (1) SG176163A1 (pt)
TW (1) TW201100404A (pt)
WO (1) WO2010133528A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2755348C (en) * 2009-03-25 2017-12-12 Abbott Laboratories Substituted aryl antiviral compounds and uses thereof
EP2632261B1 (en) 2010-10-26 2016-07-13 Presidio Pharmaceuticals, Inc. Inhibitors of hepatitis c virus
TWI566701B (zh) * 2012-02-01 2017-01-21 日本農藥股份有限公司 芳烷氧基嘧啶衍生物及包含該衍生物作為有效成分的農園藝用殺蟲劑及其使用方法
US20210017174A1 (en) 2018-03-07 2021-01-21 Bayer Aktiengesellschaft Identification and use of erk5 inhibitor
CN108822111A (zh) * 2018-08-02 2018-11-16 温州医科大学 一种5-(2-乙氧基苯基)-1-甲基-3-丙基-1H-吡唑并[4,3-d]嘧啶-7-酮的制备方法
EP4077310B1 (en) 2019-12-19 2024-05-01 Université de Strasbourg Sigma-1 receptor ligands and uses thereof
WO2024111390A1 (ja) * 2022-11-22 2024-05-30 学校法人帝京大学 化合物及びその製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001261377A1 (en) * 2000-05-10 2001-11-20 Smith Kline Beecham Corporation Novel anti-infectives
AR036081A1 (es) * 2001-06-07 2004-08-11 Smithkline Beecham Corp Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos
WO2003059356A2 (en) * 2001-10-30 2003-07-24 Smithkline Beecham Corporation Novel anti-infectives
KR20050065670A (ko) * 2002-11-01 2005-06-29 아보트 러보러터리즈 항감염제
EP1737836A1 (en) * 2004-03-31 2007-01-03 Monash University Antiviral agents
CN102099335A (zh) * 2008-07-23 2011-06-15 弗·哈夫曼-拉罗切有限公司 杂环抗病毒化合物

Also Published As

Publication number Publication date
KR20120024784A (ko) 2012-03-14
AU2010251272A1 (en) 2011-12-15
CA2761279A1 (en) 2010-11-25
WO2010133528A1 (en) 2010-11-25
EP2432554A1 (en) 2012-03-28
US20100297073A1 (en) 2010-11-25
AR078412A1 (es) 2011-11-09
TW201100404A (en) 2011-01-01
IL216026A0 (en) 2012-01-31
MX2011012240A (es) 2011-12-08
CN102448548A (zh) 2012-05-09
SG176163A1 (en) 2011-12-29
JP2012527420A (ja) 2012-11-08

Similar Documents

Publication Publication Date Title
BR112012005616A2 (pt) compostos antivirais heterocíclicos
BRPI1010852A2 (pt) compostos antivirais heterocíclicos
SMT201600351B (it) Composti antivirali
BRPI0916233A2 (pt) compostos heterocíclicos antivirais
BRPI1016266A2 (pt) compostos antivirais heterocíclicos
SMT201600008B (it) Composti di piridazinone
ATE539070T1 (de) Heterozyklische antivirale verbindungen
DK2427449T3 (da) Vinylindazolylforbindelser
BR112012006859A2 (pt) compostos
ECSP12011999A (es) Derivados benzamida sustituidos
BRPI1013246A2 (pt) derivados de benzofuralina
BRPI1013614A2 (pt) compostos substituídos de espiro-amida
BR112012002828A2 (pt) derivados de 5-fluorpirimidinona
DK2540728T3 (da) Heterocyklisk forbindelse
BRPI0924121A2 (pt) compostos antivirais heterocíclicos
BRPI1005525A2 (pt) compostos de azaazuleno
DK2397480T3 (da) Diazepindionderivat
BRPI0821349A2 (pt) compostos antivirais heterocíclicos
BRPI0906705A2 (pt) Composto heterocíclicos
BRPI1013844A2 (pt) derivados de piridina-isoxazol
BRPI1013493A2 (pt) composto de pirimidina
BRPI1014454A2 (pt) derivados de isoxazol-pirazol
DK2387580T3 (da) Deoxyactagardinderivater
BR112012002810A2 (pt) derivados de n1-acil-5-fluoropirimidinona
HRP20150932T1 (xx) Heterocikliäśki spojevi

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]